Gideon M. Hirschfield

机构：University Health Network · ORCID：0000-0002-6736-2255

发表论文 752 篇 · 总被引 46851 次 · h-index 103

代表论文

• Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 29)
• Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis (2025 · Journal of Hepatology · 被引 16)
• Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases (2025 · Liver International · 被引 16)
• Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results (2025 · The American Journal of Gastroenterology · 被引 14)
• Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis (2025 · Journal of Hepatology · 被引 9)
• Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver Diseases (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 8)